• Search Funds
  • Model Portfolios
  • Provider
  • Sector
  • Manager

Search by provider name

Search by sector name

Search by manager name

Search by Risk Level

Legal & General Global Health & Pharmaceuticals Index Trust (I) - Acc

  • Fund Info & charges
  • Performance
  • Fund breakdown
  • Dividend History
Fund Provider Legal & General
Fund Summary The objective of this fund is to provide growth by tracking the performance of those companies in the FTSE World Index which are engaged in Health, Pharmaceuticals and Biotechnology activities.
SEDOL code B0CNH38
ISIN GB00B0CNH387
Fund code LGGPA
Managers Not Disclosed
Manager Tenure 6 years
Morningstar Category Sector Equity Healthcare
IMA Sector Global
Fund Size £484 million
Fund Type OEIC
Management Style Passive
Total Expense Ratio (TER) 0.31%
Cavendish ongoing charge 0.05%
FundsNetwork Service Fee 0.20%
Minimum Initial Investment £25
Minimum Top Up £25
Minimum Monthly Investment £25
Sell Price £0.8698
Buy Price £0.8715
Price Change +0.1724%
Price Date 17th July 2019
Yield 1.40%
Dividend Frequency Yearly
ISA Eligible Yes
SIPP Eligible Yes
Inception Date 1st November 2000
Fund Status OPEN

3-year Mean Monthly Return: 0.894%

Annual Returns 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009
Fund Performance +12.69% +4.54% +14.69% +12.05% +25.74% +14.39% +30.84% +8.17% +18.65% +19.44%
Benchmark Performance
(Sector Equity Healthcare)
+8.01% +4.48% +9.75% +11.19% +24.65%
Time Period Cumulative Benchmark Performance
(Sector Equity Healthcare)
Fund Compared to Benchmark
1 day 0.16% -0.15% +0.31%
1 week -0.50% +1.50% -2.00%
1 month 3.09% +3.69% -0.59%
3 months 11.00% +1.52% +9.48%
6 months 9.55% +1.20% +8.34%
1 year 11.57% +6.07% +5.50%
3 years 32.05% +35.37% -3.32%
5 years 95.90% +72.45% +23.45%
10 years 341.52% +284.71% +56.81%
YTD 12.28% +8.18% +4.09%
Since inception 247.92% Currently unavailable Currently unavailable

Top 10 shares for this fund

Share Name Country Value
Johnson & Johnson USA 7.75%
Pfizer Inc USA 4.74%
UnitedHealth Group Inc USA 4.68%
Merck & Co Inc USA 4.16%
Roche Holding AG Dividend Right Cert. CHE 3.78%
Novartis AG CHE 3.69%
Abbott Laboratories USA 2.77%
AbbVie Inc USA 2.49%
Medtronic PLC USA 2.46%
Amgen Inc USA 2.36%
Dividend Date Per share amount Reinvestment Price
8th January 2019 0.0113 £0.7939
8th January 2018 0.0104 £0.7341
9th January 2017 0.0096 £0.6802
8th January 2016 0.0075 £0.5682
8th January 2015 0.0071 £0.5451
8th January 2014 0.0068 £0.4153